Screening markers for chronic atrophic gastritis in Chiapas, Mexico

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 2, 2001, Pages 107-112

  Ley, C ^a   Mohar, A ^a   Guarner, J ^a   Herrera Goepfert, R ^a   Figueroa, L S ^a   Halperin, D ^a   Parsonnet, J ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIN; PEPSINOGEN;

ADULT; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; GASTRIN BLOOD LEVEL; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; SCREENING TEST;

ADULT; AGE DISTRIBUTION; AGED; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CHRONIC DISEASE; CONFIDENCE INTERVALS; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MASS SCREENING; MEXICO; MIDDLE AGED; PEPSINOGEN A; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 0035117571     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mortality by cause for eight regions of the world: Global burden of disease study
2. Intestinal type: Diffuse type ratio of gastric carcinoma in a Mexican population
3. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma: A population-based study in Sweden
4. Gastric cancer in Colombia. III. Natural history of precursor lesions
5. The ratio of pepsinogen A to pepsinogen C: A sensitive test for atrophic gastritis
6. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis
7. Evaluation of pepsinogen A and gastrin-17 as markers of gastric cancer and high-risk pathologic conditions
8. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis
9. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis
10. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: Development of a biomarker strategy for gastric atrophy in high-risk groups
11. Serological parameters in assessment of degree of gastritis in healthy volunteers
12. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
13. Serum pepsinogens as a screening test of extensive chronic gastritis
14. Cytotoxin-associated gene A-positive Helicobacter pylori infection in the elderly
15. Serum group 1 pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer
16. Relationships among serum pepsinogen 1, serum pepsinogen II and gastric mucosal histology
17. Seroepidemiology of gastritis in Japanese and Dutch working populations: Evidence for the development of atrophic gastritis that is not related to Helicobacter pylori
18. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis
19. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia
20. Clinical significance of pepsinogen A isozymogens, serum pepsinogens A and C levels, and serum gastrin levels
21. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer
22. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population
23. Seroprevalence of CagA positive strains among Helicobacter pylori-infected healthy young adults
24. Analytical and clinical evaluation of a radioimmunoassay for gastrin
25. Classification and grading of gastritis: The updated Sydney system
26. Incidence of atrophic gastritis with age in Japan and Canada
27. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico
28. Stomach cancer cluster in Mexico (published erratum appears in Lancet, 2: 524, 1988)
29. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection
30. Significance of serum markers pepsinogen I and II for chronic atrophic gastritis, peptic ulcer and gastric cancer
31. Variability in serum pepsinogen levels in an asymptomatic population
32. Helicobacter pylori infection and atrophic gastritis in the elderly
33. Gastric atrophy and regional variation in upper gastrointestinal disease
34. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: Studies in asymptomatic Japanese adults
35. Histological diagnosis of precancerous lesions of the stomach: A reliability study